CN1562256A - Prepared Chinese medicine for treating upper respiratory tract infection - Google Patents
Prepared Chinese medicine for treating upper respiratory tract infection Download PDFInfo
- Publication number
- CN1562256A CN1562256A CN 200410023752 CN200410023752A CN1562256A CN 1562256 A CN1562256 A CN 1562256A CN 200410023752 CN200410023752 CN 200410023752 CN 200410023752 A CN200410023752 A CN 200410023752A CN 1562256 A CN1562256 A CN 1562256A
- Authority
- CN
- China
- Prior art keywords
- radix scutellariae
- respiratory tract
- tract infection
- upper respiratory
- chinese patent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
A Chinese patent medicine for treating upper respiratory tract infections, sporadic encephalitis, and viral hepatitis is prepared from 5 Chinese-medicinal materials including honeysuckle flower, dandelion herb, forsythia fruit, scutellaria root, etc.
Description
Technical field
The present invention relates to medicine, is a kind of Chinese patent medicine for the treatment of upper respiratory tract infection.
Background technology
Because respiratory tract infection is normally caused by virus or antibacterial, so various types of medicine is more.Because antibiotic side effect is bigger, the patient generally at first selects Chinese patent drugs for treatment, and the kind that the therapeutic effect of present pure Chinese medicine product is good, produce effects is fast is few, particularly treats the respiratory tract infection that is caused by virus.
Summary of the invention
The objective of the invention is, a kind of Chinese patent medicine for the treatment of upper respiratory tract infection is provided, it mainly treats the respiratory tract infection that is caused by virus, also can treat diseases such as sporadic encephalitis and viral hepatitis, advantages such as side effect is little, produce effects is fast, transference cure is fast, therapeutic effect is good that it has.
The present invention provides following technical scheme in order to finish goal of the invention: it is made up of the raw material of following weight parts: Flos Lonicerae 10-20g, Herba Taraxaci 15-25g, Fructus Forsythiae 10-20g, Radix Scutellariae 20-30g, Herba Violae 15-25g.It also can be made up of the raw material of following weight parts: Flos Lonicerae 16.7g, Herba Taraxaci 20g, Fructus Forsythiae 16.7g, Radix Scutellariae 26.6g, Herba Violae 20g.Its product forms is a sugar coated tablet.Preparation method of the present invention is: with Flos Lonicerae, Herba Taraxaci, Fructus Forsythiae, Radix Scutellariae, Herba Violae is by after the described proportioning weighing, the Radix Scutellariae decocting liquid of 1/3-1/4 amount is made diluent, all the other add the water logging bubble of 4 times of amounts, decoct 2 times, each about 60 minutes, the decocting liquid that merges twice filters, and be concentrated into the silk fabric paste, adding the Radix Scutellariae fluid diluent again stirs and makes soft material, under 70-80 ℃ of condition, dry, be ground into fine powder, do binding agent with the ethanol of 75-80% and make 16-18 order granule, the magnesium stearate that adds 0.5-1% behind the granulate is pressed into every sugar coated tablet packing that contains crude drug 1 gram.
Component of the present invention has the dampness effect concurrently on the heat-clearing and toxic substances removing basis.The combination of Flos Lonicerae and Radix Scutellariae can eliminating fire and detoxication, again can heat clearing and damp drying, and it is better that Fructus Forsythiae and Flos Lonicerae can produce the heat-clearing and toxic substances removing effect, Herba Taraxaci and Radix Scutellariae combination, dampness power is stronger, increases Herba Violae on the basis of above-mentioned compatibility, more helps heat-clearing and toxic substances removing and does not produce other untoward reaction.
The present invention treats through clinical 920 routine upper respiratory tract infection, matched group 348 examples, and 23 routine viral hepatitis hepatitis A treatments, matched group 20 examples, 26 examples are organized in the sporadic encephalitis treatment, matched group 20 examples.Upper respiratory tract infection symptoms complete obiteration in 1-5 days, average 3.06 days transference cures, average 4 days transference cures of matched group.The sporadic encephalitis patient, the treatment group is produce effects after 3 days.Cure rate was 76% in 7 days, and 7 days treatment rates of matched group are 39%, and 10 days cure rates of treatment group are 92%, 10 days cure rates 65% of matched group.The viral hepatitis treatment group, the hepatitis A transference cure time is 12 days, laboratory inspection such as liver function, icteric index index normal time is 18.2 days, the matched group transference cure time is 15.6 days, laboratory inspection such as liver function, icteric index index normal time is 22.56 days, in treatment, observe hemogram, liver function, renal function and heart rate, blood pressure, electrocardiogram simultaneously and have or not erythra, pruritus etc., do not find influence to leukocyte Hb, Ptt, hepatic and renal function, do not see that erythra, pruritus symptom take place, simultaneously, there is not the untoward reaction of symptoms such as the nauseating gastrointestinal of diarrhoea yet.Medicine of the present invention has definite very significantly antiviral therapy effect.The present invention is using the white mice measuring in acute toxicity testing, because the acute toxicity of medicine of the present invention is lower, fail to measure LD
5, the maximum anti-amount of the awarding MTD that records at the invention medicine of experiment, 325g/kg that is: is equivalent to 150 times of clinical maximum dosage-feeding 0.0214g/Kg, observes a week continuously, during survival good, normally none death of spirit.
Medicine of the present invention has advantage such as have no side effect, produce effects is fast, transference cure is fast, therapeutic effect is good, and the present invention treats diseases such as upper respiratory tract infection, influenza, sporadic encephalitis and viral hepatitis.
The specific embodiment
The present invention is not limited only in the scope of embodiments, and the preparation method of the embodiment of the invention is identical with above-mentioned preparation method, and the present invention not detailed description is known technology.
1, extracting honeysuckle 12g, Herba Taraxaci 15g, Radix Scutellariae 23g, Fructus Forsythiae 12g, Herba Violae 18g, Radix Scutellariae 7.66g is soaked 2 times to be decocted, decocting liquid is made diluent, all the other add the water logging bubble of 4 times of amounts, decoct 2 times, each 60 minutes, the decocting liquid that merges twice filters, and be concentrated into the silk fabric paste, and add the Radix Scutellariae fluid diluent again and stir and make soft material, under 70 ℃ of conditions, dry, be ground into fine powder, do binding agent with 75% ethanol and make 16-18 order granule, add 0.5% magnesium stearate behind the granulate, be pressed into every sugar coated tablet packing that contains crude drug 1 gram.Prepare according to the method for the invention.
2, extracting honeysuckle 16.7g, Herba Taraxaci 20g, Fructus Forsythiae 16.7g, Radix Scutellariae 26.6g, Herba Violae 20g, Radix Scutellariae 8.86g is soaked 2 times to be decocted, decocting liquid is made diluent, all the other add the water logging bubble of 4 times of amounts, decoct 2 times, each 65 minutes, the decocting liquid that merges twice filters, and be concentrated into the silk fabric paste, and add the Radix Scutellariae fluid diluent again and stir and make soft material, under 75 ℃ of conditions, dry, be ground into fine powder, do binding agent with 77% ethanol and make 16-18 order granule, add 0.7% magnesium stearate behind the granulate, be pressed into every sugar coated tablet packing that contains crude drug 1 gram.Prepare according to the method for the invention.
3, extracting honeysuckle 20g, Herba Taraxaci 22g, Fructus Forsythiae 20g, Radix Scutellariae 18g, Herba Violae 15g, Radix Scutellariae 4.5g is soaked 2 times to be decocted, decocting liquid is made diluent, all the other add the water logging bubble of 4 times of amounts, decoct 2 times, each 58 minutes, the decocting liquid that merges twice filters, and be concentrated into the silk fabric paste, and add the Radix Scutellariae fluid diluent again and stir and make soft material, under 77 ℃ of conditions, dry, be ground into fine powder, do binding agent with 79% ethanol and make 16-18 order granule, add 0.6% magnesium stearate behind the granulate, be pressed into every sugar coated tablet packing that contains crude drug 1 gram.Prepare according to the method for the invention.
4, extracting honeysuckle 13g, Herba Taraxaci 18g, Fructus Forsythiae 15g, Radix Scutellariae 20g, Herba Violae 25g, Radix Scutellariae 5g is soaked 2 times to be decocted, decocting liquid is made diluent, all the other add the water logging bubble of 4 times of amounts, decoct 2 times, each 62 minutes, the decocting liquid that merges twice filters, and be concentrated into the silk fabric paste, and add the Radix Scutellariae fluid diluent again and stir and make soft material, under 80 ℃ of conditions, dry, be ground into fine powder, do binding agent with 80% ethanol and make 16-18 order granule, add 1% magnesium stearate behind the granulate, be pressed into every sugar coated tablet packing that contains crude drug 1 gram.Prepare according to the method for the invention.
Claims (4)
1, a kind of Chinese patent medicine for the treatment of upper respiratory tract infection, it is characterized in that: it is made up of the raw material of following weight parts: Flos Lonicerae 10-20g, Herba Taraxaci 15-25g, Fructus Forsythiae 10-20g, Radix Scutellariae 20-30g, Herba Violae 15-25g.
2, a kind of Chinese patent medicine for the treatment of upper respiratory tract infection according to claim 1, it is characterized in that: it is made up of the raw material of following weight parts: Flos Lonicerae 16.7g, Herba Taraxaci 20g, Fructus Forsythiae 16.7g, Radix Scutellariae 26.6g, Herba Violae 20g.
3, a kind of Chinese patent medicine for the treatment of upper respiratory tract infection according to claim 1, it is characterized in that: its product forms is a sugar coated tablet.
4, the preparation method of Chinese patent medicine according to claim 1, it is characterized in that: with Flos Lonicerae, Herba Taraxaci, Fructus Forsythiae, Radix Scutellariae, Herba Violae is by after the described proportioning weighing, the Radix Scutellariae decocting liquid of 1/3-1/4 amount is made diluent, all the other add the water logging bubble of 4 times of amounts, decoct 2 times, each about 60 minutes, the decocting liquid that merges twice filters, and be concentrated into the silk fabric paste, and add the Radix Scutellariae fluid diluent again and stir and make soft material, under 70-80 ℃ of condition, dry, be ground into fine powder, do binding agent with the ethanol of 75-80% and make 16-18 order granule, add the magnesium stearate of 0.5-1% behind the granulate, be pressed into every sugar coated tablet packing that contains crude drug 1 gram.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100237526A CN1298356C (en) | 2004-03-19 | 2004-03-19 | Prepared Chinese medicine for treating upper respiratory tract infection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100237526A CN1298356C (en) | 2004-03-19 | 2004-03-19 | Prepared Chinese medicine for treating upper respiratory tract infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1562256A true CN1562256A (en) | 2005-01-12 |
| CN1298356C CN1298356C (en) | 2007-02-07 |
Family
ID=34480300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100237526A Expired - Fee Related CN1298356C (en) | 2004-03-19 | 2004-03-19 | Prepared Chinese medicine for treating upper respiratory tract infection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1298356C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1326536C (en) * | 2005-09-05 | 2007-07-18 | 石洪波 | Pharmaceutical composition for treating and preventing respiratory tract viral infection, its preparation process and application |
| CN101480451B (en) * | 2008-12-18 | 2012-10-17 | 无锡济民可信山禾药业股份有限公司 | Prescription for treating upper respiratory tract infection and use thereof |
| CN104920863A (en) * | 2015-06-09 | 2015-09-23 | 柳州市柳南区明达鸽业养殖协会 | Pigeon sand capable of preventing and treating upper respiratory infection of meat pigeons |
| CN109010642A (en) * | 2018-10-11 | 2018-12-18 | 方向坤 | A kind of Chinese medicine composition and preparation method thereof for treating fever |
| CN112546128A (en) * | 2020-12-26 | 2021-03-26 | 无锡济煜山禾药业股份有限公司 | Capsule for treating upper respiratory tract infection and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1052902C (en) * | 1996-01-15 | 2000-05-31 | 贺力坤 | Method for preparation of drug for curing acute epidemic febrile disease |
| CN1244421A (en) * | 1999-05-27 | 2000-02-16 | 刘成业 | Preparation of antiviral Guzaoke |
-
2004
- 2004-03-19 CN CNB2004100237526A patent/CN1298356C/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1326536C (en) * | 2005-09-05 | 2007-07-18 | 石洪波 | Pharmaceutical composition for treating and preventing respiratory tract viral infection, its preparation process and application |
| CN101480451B (en) * | 2008-12-18 | 2012-10-17 | 无锡济民可信山禾药业股份有限公司 | Prescription for treating upper respiratory tract infection and use thereof |
| CN104920863A (en) * | 2015-06-09 | 2015-09-23 | 柳州市柳南区明达鸽业养殖协会 | Pigeon sand capable of preventing and treating upper respiratory infection of meat pigeons |
| CN109010642A (en) * | 2018-10-11 | 2018-12-18 | 方向坤 | A kind of Chinese medicine composition and preparation method thereof for treating fever |
| CN112546128A (en) * | 2020-12-26 | 2021-03-26 | 无锡济煜山禾药业股份有限公司 | Capsule for treating upper respiratory tract infection and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1298356C (en) | 2007-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100349597C (en) | Chinese medicinal preparation for treating virus myocaraitis, its preparation method and quality control method | |
| CN102397372A (en) | Medicinal composition and pharmaceutical preparation and application thereof to treating irritable bowel syndrome | |
| CN1298356C (en) | Prepared Chinese medicine for treating upper respiratory tract infection | |
| CN102697935A (en) | Chinese medicinal particle for preventing and treating duck plague and preparation method thereof | |
| CN106389757A (en) | Diabetic nephropathy treating pharmaceutical composition, preparation method and uses thereof | |
| CN101085066B (en) | Medicine for curing viral hepatitis of duckling | |
| CN104069194B (en) | A kind of Chinese medicine composition with antitumaous effect and its production and use | |
| CN104721508B (en) | A kind of pharmaceutical composition and preparation method for treating the infection of the upper respiratory tract | |
| CN105998041B (en) | Rosmarinic acid -4-O- β-D-Glucose glycosides is preparing the application in controlling flu pharmaceutical in advance | |
| CN104644759A (en) | Health tea for preventing and/or treating influenza and preparation method thereof | |
| CN103961441A (en) | Traditional Chinese medicine compound preparation, preparation method and medicine box thereof | |
| CN108096318A (en) | Treat pharmaceutical composition of cardiovascular and cerebrovascular disease and its preparation method and application | |
| CN104367781A (en) | Delicious traditional Chinese medicine with efficacy of improving immunity, moistening lung and adjusting fat, and preparation method and application thereof | |
| CN102697800B (en) | Herba stellariae mediae polysaccharide composition and the application in preparation antiviral drugs thereof | |
| CN101816706B (en) | Chinese traditional medicament valid target composition for treating viral respiratory infection diseases | |
| CN1827138A (en) | Chinese medicine composition prescription for treating cardiovascular and cerebrovascular diseases and preparation technique thereof | |
| CN103393738B (en) | Traditional Chinese medicine composition for preventing influenza A viruses H1N1 | |
| CN106309764A (en) | Chinese patent medicine for treating upper respiratory infection | |
| CN113101331B (en) | Thyme herb tea and preparation method and application thereof | |
| CN1634426A (en) | Composition of fresh rehmannia root and rhubarb horsetails and preparation method thereof | |
| CN102133336A (en) | Traditional Chinese medicine composite, and preparation method and application thereof | |
| CN103989894A (en) | Lozenge capable of improving anoxia endurance, and preparation method and application thereof | |
| CN102058668A (en) | Traditional Chinese medicinal preparation for treating primary thrombocytopenia | |
| CN100459997C (en) | Composition of bitter tea and rhubarb horsetails and preparation method thereof | |
| CN108478760A (en) | A kind of Chinese medicine composition for treating enterogastritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |